Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Min Shen
Affiliation
National Center for Advancing Translational Sciences, National Institutes of Health
ORCID
Career Start Year
2003
Papers
205
H Index
56
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36914816
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers.
Nat Cancer
2023
37894327
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms.
Cancers (Basel)
2023
37683456
Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells.
Biochem Biophys Res Commun
2023
37453329
An electrophilic fragment screening for the development of small molecules targeting caspase-2.
Eur J Med Chem
2023
37244126
Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4.
Redox Biol
2023
36976909
Target Class Profiling of Small-Molecule Methyltransferases.
ACS Chem Biol
2023
36914816
SULT1A1-dependent sulfonation of alkylators is a lineage-dependent vulnerability of liver cancers.
Nat Cancer
2023
37894327
Novel Therapeutic Strategies Exploiting the Unique Properties of Neuroendocrine Neoplasms.
Cancers (Basel)
2023
37683456
Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells.
Biochem Biophys Res Commun
2023
37453329
An electrophilic fragment screening for the development of small molecules targeting caspase-2.
Eur J Med Chem
2023
37244126
Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4.
Redox Biol
2023
36976909
Target Class Profiling of Small-Molecule Methyltransferases.
ACS Chem Biol
2023
33481411
Correlation Between Symptom Clusters and Quality of Life in Children With Acute Leukemia During Chemotherapy.
Cancer Nurs
2022
35648838
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19.
ACS Infect Dis
2022
36151566
Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
J Exp Clin Cancer Res
2022
36268125
Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen.
ACS Pharmacol Transl Sci
2022
35357819
Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity.
J Chem Inf Model
2022
35404596
Graph Convolutional Network-Based Screening Strategy for Rapid Identification of SARS-CoV-2 Cell-Entry Inhibitors.
J Chem Inf Model
2022
36439493
Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells <i>via</i> an inhibition of CaMKII/CREB1 mediated ABCB1 expression.
Front Oncol
2022
33481411
Correlation Between Symptom Clusters and Quality of Life in Children With Acute Leukemia During Chemotherapy.
Cancer Nurs
2022
35312769
GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling.
Mol Cancer Ther
2022
35169799
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19.
bioRxiv
2022
34417224
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic Leukemia.
Cancer Discov
2022
35086793
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry.
SLAS Discov
2022
35103473
Discovery of Small-Molecule VapC1 Nuclease Inhibitors by Virtual Screening and Scaffold Hopping from an Atomic Structure Revealing Protein-Protein Interactions with a Native VapB1 Inhibitor.
J Chem Inf Model
2022
34472587
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.
Brief Bioinform
2022
35648838
Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19.
ACS Infect Dis
2022
35404596
Graph Convolutional Network-Based Screening Strategy for Rapid Identification of SARS-CoV-2 Cell-Entry Inhibitors.
J Chem Inf Model
2022
35357819
Virtual Screening for the Discovery of Microbiome β-Glucuronidase Inhibitors to Alleviate Cancer Drug Toxicity.
J Chem Inf Model
2022
36439493
Terfenadine resensitizes doxorubicin activity in drug-resistant ovarian cancer cells <i>via</i> an inhibition of CaMKII/CREB1 mediated ABCB1 expression.
Front Oncol
2022
36268125
Discovery of Novel Small-Molecule Scaffolds for the Inhibition and Activation of WIP1 Phosphatase from a RapidFire Mass Spectrometry High-Throughput Screen.
ACS Pharmacol Transl Sci
2022
36151566
Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
J Exp Clin Cancer Res
2022
35312769
GPC1-Targeted Immunotoxins Inhibit Pancreatic Tumor Growth in Mice via Depletion of Short-lived GPC1 and Downregulation of Wnt Signaling.
Mol Cancer Ther
2022
35086793
A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry.
SLAS Discov
2022
35169799
A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19.
bioRxiv
2022
35103473
Discovery of Small-Molecule VapC1 Nuclease Inhibitors by Virtual Screening and Scaffold Hopping from an Atomic Structure Revealing Protein-Protein Interactions with a Native VapB1 Inhibitor.
J Chem Inf Model
2022
34472587
Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments.
Brief Bioinform
2022
34417224
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by <i>NSD2</i> Mutation in Pediatric Acute Lymphoblastic Leukemia.
Cancer Discov
2022
33468482
Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing Screen.
Antimicrob Agents Chemother
2021
33689873
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection.
Bioorg Med Chem Lett
2021
33468482
Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing Screen.
Antimicrob Agents Chemother
2021
33831697
Identification of SARS-CoV-2 viral entry inhibitors using machine learning and cell-based pseudotyped particle assay.
Bioorg Med Chem
2021
34144038
Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles.
J Biol Chem
2021
33932049
Autocatalytic activation of a malarial egress protease is druggable and requires a protein cofactor.
EMBO J
2021
33822623
Discovery and Optimization of 2<i>H</i>-1λ<sup>2</sup>-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer.
J Med Chem
2021
34136758
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19.
ACS Pharmacol Transl Sci
2021
33708112
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2.
Front Pharmacol
2021
33300000
Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments.
bioRxiv
2021
33346633
The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules.
ACS Infect Dis
2021
33398276
Discovery of TMPRSS2 inhibitors from virtual screening.
bioRxiv
2021
1 - 50 of 410
Column Actions
Search
Recommended Authors
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year
2011
Number of shared co-authors
1
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Daizhan Zhou
The Fourth Affiliated Hospital, Zhejiang University School of Medicine
Career Start Year
2008
Number of shared co-authors
0
Andrew T Magis
Institute for Systems Biology
Career Start Year
2007
Number of shared co-authors
0
Hyun Seok Kim
Seoul National University
Career Start Year
2005
Number of shared co-authors
0
Guan Wang
Jilin University
Career Start Year
2005
Number of shared co-authors
0
Abul Kalam Azad
University of Dhaka
Career Start Year
2004
Number of shared co-authors
1
Mandeep Kaur
Post Graduate Institute of Medical Education and Research
Career Start Year
2003
Number of shared co-authors
0
Minya Pu
University of California
Career Start Year
2003
Number of shared co-authors
0
Keyue Ding
Queen's University
Career Start Year
2002
Number of shared co-authors
1
Amjad Ali
Research Institute for Medical and Health Sciences, University of Sharjah
Career Start Year
2001
Number of shared co-authors
0
William H Bisson
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2001
Number of shared co-authors
1
Vivek Shukla
Chalmers University of Technology
Career Start Year
2000
Number of shared co-authors
7
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
25
Sunkyu Kim
Korea University
Career Start Year
2000
Number of shared co-authors
3
Kerby Shedden
University of Michigan ann arbor
Career Start Year
1999
Number of shared co-authors
0
Liewei Wang
Mayo Clinic
Career Start Year
1999
Number of shared co-authors
5
Chao Xing
University of Texas Southwestern Medical Center
Career Start Year
1999
Number of shared co-authors
4
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year
1998
Number of shared co-authors
3
Mahadev Rao
Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences
Career Start Year
1998
Number of shared co-authors
3
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year
1998
Number of shared co-authors
0
Chun-Liang Chen
National Dong Hwa University
Career Start Year
1997
Number of shared co-authors
1
Ting Xu
Jiangsu Food & Pharmaceutical Science College
Career Start Year
1997
Number of shared co-authors
5
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year
1994
Number of shared co-authors
8
Huy Nguyen
The University of Danang-University of Science and Technology
Career Start Year
1993
Number of shared co-authors
4
Bing Xia
Xijing Hospital, The Fourth Military Medical University
Career Start Year
1992
Number of shared co-authors
2
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year
1989
Number of shared co-authors
0
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
1988
Number of shared co-authors
0
Tian Tian
Beijing Friendship Hospital, Capital Medical University
Career Start Year
1988
Number of shared co-authors
3
Brent W Zanke
University of Toronto
Career Start Year
1987
Number of shared co-authors
17
row(s) 1 - 30 of 30
Collaborators
Roel Vermeulen
Co-authored papers
39
Anton Simeonov
Co-authored papers
37
Matthew B Boxer
Co-authored papers
35
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers
32
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers
22
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Co-authored papers
18
Sam Michael
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
17
Zhuyin Li
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
14
Sonja I Berndt
Co-authored papers
14
Christopher P Austin
St. George's University Medical School
Co-authored papers
14
Ajit Jadhav
Co-authored papers
14
Robert Welch
Co-authored papers
13
Neil E Caporaso
National Cancer Institute, National Institutes of Health
Co-authored papers
11
Richard B Hayes
Co-authored papers
10
Electron Kebebew
Stanford University School of Medicine
Co-authored papers
10
Lisa Zhang
National Institute of Child Health and Development
Co-authored papers
10
Yaqin Zhang
Jiangsu University Zhenjiang 212013
Co-authored papers
8
Myriem Boufraqech
The University of Texas at Austin
Co-authored papers
8
Lewis C Cantley
Co-authored papers
8
Marc Ferrer
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers
7
Donald C Lo
National Center for Advancing Translational Sciences
Co-authored papers
6
Martin J Walsh
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers
6
Demetrius Albanes
Co-authored papers
5
Paolo Boffetta
Co-authored papers
5
Stephanie J Weinstein
Co-authored papers
5
Naris Nilubol
Center for Cancer Research
Co-authored papers
5
Jarmo Virtamo
Co-authored papers
4
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers
4
Amit Mehta
Center for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth
Co-authored papers
4
Joseph F Fraumeni
National Cancer Institute
Co-authored papers
4
1 - 30